The Safety of Tenofovir–Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals With Active Hepatitis B

BACKGROUND: Pre-exposure prophylaxis (PrEP) with daily oral emtricitabine and tenofovir disoproxil fumarate (FTC/TDF) prevents HIV infection. The safety and feasibility of HIV PrEP in the setting of hepatitis B virus (HBV) infection were evaluated. METHODS: The Iniciativa Profilaxis Pre-Exposición s...

Descripción completa

Detalles Bibliográficos
Autores principales: Solomon, Marc M., Schechter, Mauro, Liu, Albert Y., McManhan, Vanessa M., Guanira, Juan V., Hance, Robert J., Chariyalertsak, Suwat, Mayer, Kenneth H., Grant, Robert M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JAIDS Journal of Acquired Immune Deficiency Syndromes 2016
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752387/
https://www.ncbi.nlm.nih.gov/pubmed/26413853
http://dx.doi.org/10.1097/QAI.0000000000000857

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752387/
https://www.ncbi.nlm.nih.gov/pubmed/26413853
http://dx.doi.org/10.1097/QAI.0000000000000857

Ejemplares similares